Colorado was the first state to cap a drug’s price – then a federal court stepped in

The pharmaceutical company Amgen argues that Colorado's price cap interferes with federal patent law. philipdyer/iStock via Getty Images Plus Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set upper limits on what state agencies, insurers and other purchasers may pay or be reimbursed for certain high-cost drugs dispensed to patients in the state. In fall 2025, the Colorado board capped Enbrel, an immunosuppressant drug…